Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001641172-25-022104
Filing Date
2025-08-05
Accepted
2025-08-04 17:53:54
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B3 form424b3.htm 424B3 1148531
2 GRAPHIC form424b3_001.jpg GRAPHIC 15567
3 GRAPHIC form424b3_002.jpg GRAPHIC 40816
4 GRAPHIC form424b3_003.jpg GRAPHIC 2471
  Complete submission text file 0001641172-25-022104.txt   1231170
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-288911 | Film No.: 251181925
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)